Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smoke Free Support Study 2.0
NCT03808818Completed
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Start
- Aug 2019
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by ECOG-ACRIN Cancer Research Group. Primary endpoint: Biochemically-verified 7-day Point Prevalence Abstinence at 6 months. Started Aug 2019; status: completed.
Beyond the preview
Go deeper on NCT03808818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03808818.